Camargo Recognized As One Of Cincinnati's 2009 Fast 55

Camargo Pharmaceutical Services is pleased to be recognized as one of Cincinnati's 55 fastest-growing private companies in the Greater Cincinnati region for 2009. The annual event is sponsored by the Business Courier of Cincinnati.

Companies, including Camargo, had a number of nomination criteria to meet in order to be selected for this recognition. For example, qualifying criteria included increasing revenues for the past three years as an independent, privately held, for-profit company. Eligibility for the Fast 55 award also includes that a company must be headquartered in the fifteen-county, three-state Greater Cincinnati region and have a three-year operating history.

Camargo will be attending the Fast 55 Awards Luncheon on December 10, 2009, at the Northern Kentucky Convention Center for the final award presentations. At this time, winners will be announced for each of the five revenue categories ($1-4.9M, 5-9.9M,10-49.9M, 50-199.9M and 200+ million), one of which Camargo is a finalist for.

Continuing to thrive on its business model and strategic focus, Camargo provides end-to- end drug development through the FDA 505(b)(2) drug approval process. Camargo provides the full spectrum of services to the drug development industry from discovery through each phase of clinical development. The executive leadership team at the organization is steeped in effective strategic planning and has extensive expertise in meeting the regulatory requirements for FDA approvals.

"We are pleased to be a member of the Fast 55. Our growth has been fueled by the rapidly increasing interest in improving existing drugs. Due to our experience gained by frequent interactions with the FDA, Camargo has become recognized as the world leader in the field. Our dedicated staff is the true backbone to our success, which has enabled us to have a client referral rate of 95%. We are pleased that our performance places us in the company of many other successful companies in Cincinnati. We appreciate the recognition of the impact organizations like Camargo make on the local economy," stated Camargo President and CEO, Ken Phelps.

About Camargo Pharmaceutical Services
Camargo Pharmaceutical Services is a full-service CRO for the continuum of drug development. With more than 150 FDA approvals, Camargo works with companies to develop comprehensive programs, managing every facet of the plan from formulation and testing the drug product, conducting clinical studies and FDA application submissions. Visit www.camargopharma.com for more information.

SOURCE: Camargo Pharmaceutical Services